Fremedica Technologies Inc. is a wholly owned subsidiary of Frequency Exchange Corp. The Company markets a frequency emitter that delivers the benefits of bioresonance through a lightweight, wearable device. The Fremedica product includes a special package of frequencies that support the immune system and speed recovery from Lyme disease. Lyme is the fastest-growing vector borne illness in North America. Fremedica was established in 2016 and has enjoyed rapid growth to currently serve over 1,000 customers.